Cargando…
The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity
BACKGROUND: the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking. As a result, there is no evidence from controlled studies on the efficacy of different initial doses or glucocorticoid tapering. The aim of this s...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114801/ https://www.ncbi.nlm.nih.gov/pubmed/21569559 http://dx.doi.org/10.1186/1471-2474-12-94 |